We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
- Authors
Cejka, Daniel; Jäger-Lansky, Agnes; Kieweg, Heidi; Weber, Michael; Bieglmayer, Christian; Haider, Dominik G; Diarra, Danielle; Patsch, Janina M; Kainberger, Franz; Bohle, Barbara; Haas, Martin
- Abstract
Sclerostin is a soluble inhibitor of osteoblast function. Sclerostin is downregulated by the parathyroid hormone (PTH). Here, it was investigated whether sclerostin levels are influenced by intact (i) PTH and whether sclerostin is associated with bone turnover, microarchitecture and mass in dialysis patients.
- Publication
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Vol 27, Issue 1, p226
- ISSN
1460-2385
- Publication type
Journal Article
- DOI
10.1093/ndt/gfr270